A new era of biopharma R&D: The TechBio revolution—realities and the next frontier

Join Tempus and Recursion leaders to explore their strategic TechBio partnership. Learn how they use AI and supercomputing with petabytes of data to accelerate drug discovery and development. See the impact on biopharma R&D's future.

Nov 21, 2025
Life Sciences
Webinar
Black and white headshot of a smiling man wearing glasses and a suit jacket.Sid JainSenior Vice President of Clinical, Development & Data Science, Recursion
Black and white headshot of a smiling woman with long dark hair and hoop earrings.Hayley Donnella, PhDVice President of Frontier Research, Recursion
Smiling man with a dark beard and short hair in a black and white headshot.Shane Woods, PhDChief Strategy Officer, Tempus

Session highlights

  • Integrates Tempus’ multimodal data with Recursion’s high-throughput screening to ground experimental findings and validate therapeutic targets

  • Translates insights from real-world data into actionable therapeutic strategies, from preclinical discovery to clinical trial design and execution

  • Addresses operational hurdles in unifying disparate data and leverages key learnings to drive the next wave of what’s possible in techbio